A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO.

Abstract

BACKGROUND/PURPOSE Intracranial hemorrhage (ICH), is a major source of morbidity and the leading cause of death in neonates treated with extracorporeal membrane oxygenation (ECMO). Anecdotal reports have suggested that epsilon-aminocaproic acid (EACA) can decrease the risk of ICH. The purpose of this study was to evaluate, in a multiinstitutional… (More)

Topics

Cite this paper

@article{Horwitz1998AMT, title={A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO.}, author={Jay R. Horwitz and Barry R. Cofer and Brad W. Warner and H W Cheu and Kevin P. Lally}, journal={Journal of pediatric surgery}, year={1998}, volume={33 11}, pages={1610-3} }